The evolution of stem-cell transplantation in multiple myeloma.

about

The evolution of stem-cell transplantation in multiple myeloma.

Item

http://www.wikidata.org/entity/Q52715329

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The evolution of stem-cell transplantation in multiple myeloma.

@en

The evolution of stem-cell transplantation in multiple myeloma.

@nl

type

Item

label

The evolution of stem-cell transplantation in multiple myeloma.

@en

The evolution of stem-cell transplantation in multiple myeloma.

@nl

prefLabel

The evolution of stem-cell transplantation in multiple myeloma.

@en

The evolution of stem-cell transplantation in multiple myeloma.

@nl

P1476

The evolution of stem-cell transplantation in multiple myeloma

@en

P2093

Sarakshi Mahajan

http://www.w3.org/2001/XMLSchema#string

Shaji Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers

Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management

Non-invasive focus localization, right ventricular epicardial potential mapping in patients with an MRI-conditional pacemaker system - a pilot study.

New investigational drugs with single-agent activity in multiple myeloma

Older patients with myeloma derive similar benefit from autologous transplantation.

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

P304

123-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040620718761776

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nidhi Tandon

P577

2018-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29713445

http://www.w3.org/2001/XMLSchema#string

P932

5900826

http://www.w3.org/2001/XMLSchema#string